Alkermes

ALKSNasdaq Ireland Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$8.249 B

$49.17 +1.65%

Close of 7 Aug 2026

Revenue

$1.48B

#1307 by revenue

Earnings

$241.7M

#923 by earnings

Shares outstanding

167,763,272

Latest filing cover page

P/E ratio

34.1

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#41Spyre TherapeuticsSYRE$9.25B
#42Crinetics PharmaceuticalsCRNX$8.92B
#43AlkermesALKS$8.25B
#44LiquidiaLQDA$8.02B
#45Rhythm PharmaceuticalsRYTM$7.96B

Where these numbers come from

Share counts and financials for Alkermes are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.